27 Phase III And 8 Phase II Alzheimer’s Drugs On Track To Launch In Next 5 Years, ResearchersAgainstAlzheimer’s Reports

Twenty-seven Alzheimer’s drugs in Phase III clinical trials and eight drugs in Phase II clinical trials may launch in the next five years, according to a revised Alzheimer's pipeline analysis presented today at the Alzheimer’s Association International Conference (AAIC). Read the full press release here.